A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
Blume-Peytavi, Ulrike, MD, Lönnfors, Sanna, MScPH, Hillmann, Kathrin, MD, Garcia Bartels, Natalie, MD
Published in Journal of the American Academy of Dermatology (01.05.2012)
Published in Journal of the American Academy of Dermatology (01.05.2012)
Get full text
Journal Article